Contigo Systems Inc.

Endurance Wind PowerInc.

Inimex Pharmaceuticals Inc.

In Motion Technology Inc.

Mobidia, Inc.

MSI Methylation Sciences, Inc.

Paradigm Environmental Technologies Inc.

Parasun Technologies Inc. (Succesfully Exited)

Protox Therapeutics Inc. (TSX:PRX)

Recombo Inc.

Redlen Technologies Inc.

Sirius Genomics Inc.

Venturi Ventures Inc.

Allon Therapeutics Inc. (TSX:NPC)is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon's drug davunetide intranasal (AL-108) has demonstrated human efficacy in amnestic mild cognitive impairment, a precursor to Alzheimer's disease. Allon has Phase II human efficacy programs pursuing large underserved markets: Alzheimer's disease, frontotemporal dementia, and schizophrenia-related cognitive impairment. The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" (Neuro Protection CompanyTM) and based in Vancouver.

Aquinox Pharmaceuticals Inc. is a pharmaceutical company committed to the discovery, development, and commercialization of novel and targeted small molecule therapeutics for the treatment of cancer and inflammatory disease. Aquinox's scientific founders discovered a unique biochemical enzyme called SH2-containing inositol 5'-phosphatase (known as SHIP), which can be harnessed in the treatment disorders such as multiple myeloma, leukemia, lymphoma, inflammation, allergy and autoimmune diseases.

Brightside Technologies Inc. was acquired by Dolby Laboratories in May 2007 for USD $28 million, Brightside developed High Dynamic Range image technology for the display of more vibrant pictures and video, primarily on mass-market LCD, front-projection and rear-projection television sets. BC Advantage Funds first invested in Brightside in 2004 and exited with the sale of the Company in 2007 for a 2.8X return multiple.

Contech Inc. develops, manufactures,and markets innovative, environmentally-friendly products for the commercial forestry, agriculture, and animal husbandry markets, as well as the consumer pet and garden markets.

Contigo Systems Inc. is a leading provider of location-based services using wireless and GPS technology for asset-tracking, fleet management and personal safety applications. Having commercialized a full, web-based solution for employing GPS and mobile solutions to track commercial vehicle fleets, assets and individuals, Contigo’s solutions are distributed under the same name across the U.S. and Canada through a broad network of security companies and GPS resellers.

   Endurance Wind Power Inc. is a manufacturer of advanced wind turbines designed specifically for distributed wind power applications. The company’s line of modern, induction-based wind turbines, bring efficient, reliable, safe and quiet, renewable energy within reach of homeowners, businesses and institutions across North America, the United Kingdom and an expanding global market.

Inimex Pharmaceuticals Inc. is focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing inflammation. IDR products have major market potential for infectious disease, cancer, and inflammatory disease.

In Motion Technology Inc. develops and sells a proprietary mobile gateway, called oMG that performs seamless sensing, selection and handoff for all commercially available wireless networks (WiFi, WiMAX, 2G or 3G cellular, Bluetooth, GPS).

Mobidia, Inc. provides wireless operators with the ability to better control, manage, and monetize IP data traffic and offer their mobile subscribers innovative and compelling new services.

MSI Methylation Sciences, Inc. is a life science company, focused on reformulating and developing a widely used nutraceutical, with proven safety and efficacy in humans, as a new pharmaceutical for the treatment of depression. MSI is led by an experienced management team including Barry Guld and Nancy Harrison.

Paradigm Environmental Technologies Inc. is the developer of MicroSludge™, a sludge disintegration system that vastly improves the performance of anaerobic digesters for secondary wastewater treatment plants of all sizes.

Parasun Technolgies Inc. was acquired in May 2007 for $12,500,000 by Uniserve Communications. Parasun continues to operate under its name where it provides industry-leading Broadband provisioning and management and support solutions for small and mid-tier network operators. BC Advantage Funds invested in Parasun in 2004 and exited with the sale of the Company for a 4.7X return multiple.

Protox Therapeutics Inc. (TSX:PRX) is at the forefront of developing novel treatments in the emerging field of targeted toxin therapeutics for the treatment of cancer and other proliferative diseases. The company is actively developing two distinct but complementary platforms, INxin(TM) and PORxin(TM), in the development of therapeutic products for its clinical programs.

Recombo Inc. is a leading provider of online agreement and secure electronic signature/digital signature software. Recombo WAYPOINT™ is an online service that lets businesses complete any contract or agreement through email and the internet.

Redlen Technologies Inc. manufactures semiconductor compounds (Cadmium Telluride and Cadmium Zinc Telluride), as well as integrated radiation detectors using these compounds. These products are used in a wide variety of industries including nuclear medical imaging, homeland security and thin-film solar.

Sirius Genomics Inc. is a pharmacogenomics and diagnostics company developing DNA-based diagnostic (Dx) and pharmacogenetic (PGx) tests for critical care. Sirius’ product focus is currently concentrated on the development of Dx and PGx tests for sepsis, a systemic blood infection.